Suppr超能文献

无泵体外肺辅助——前20例经验

Pumpless extracorporeal lung assist - experience with the first 20 cases.

作者信息

Liebold A, Reng C M, Philipp A, Pfeifer M, Birnbaum D E

机构信息

Department of Cardiothoracic, University of Regensburg, Surgery, Franz-Josef-Strauss-Allee 11, 93042, Regensburg, Germany.

出版信息

Eur J Cardiothorac Surg. 2000 May;17(5):608-13. doi: 10.1016/s1010-7940(00)00389-4.

Abstract

OBJECTIVE

Long-term extracorporeal lung assist is limited by a significant mechanical blood trauma resulting in bleeding and hemolysis. To reduce the drawbacks of extracorporeal lung assist a new technique has been developed, by which the driving force for the extracorporeal circuit derives from the patients arterio-venous pressure gradient (pumpless extracorporeal lung assist). The aim of this clinical study was to test the feasibilty and effectiveness of pumpless extracorporeal lung assist in patients with acute respiratory distress syndrome.

METHODS

Twenty patients (41+/-16 years) with acute respiratory distress syndrome of various causes and failing respirator therapy were enrolled. The minimum hemodynamic requirements included a cardiac output (CO) >6 l/min and mean arterial pressure (MAP) >70 mmHg. Pumpless extracorporeal lung assist was established using a short circuit arterio-venous shunt including a special designed low-resistance membrane oxygenator which was placed between the patients legs.

RESULTS

At the time of inclusion FiO(2) in all patients was 1.0 (paO(2) 45.9+/-7 mmHg, paCO(2) 58.9+/-17 mmHg). After 24 h of pumpless extracorporeal lung assist FiO(2) was reduced to 0.8+/-0.1. A significant improvement in oxygenation (paO(2) 84.1+/-21 mmHg, P<0.05) and CO(2) removal (paCO(2) 32.7+/-5 mmHg, P<0.05) was notable. The mean extracorporeal flow was 2.6+/-0.6 l/min, which represented approximately 25% of the patients mean CO (10.8+/-2 l/min). The median assist time was 12+/-8 (1-32) days. Fifteen out of twenty patients were weaned off pumpless extracorporeal lung assist. Five out of twenty patients died while on the system (four sepsis, one ventricular fibrillation). Three out of twenty patients died after successful weaning on day 8, 30, and 50, respectively. Twelve out of twenty patients were discharged in a healthy state (overall survival 60%). Technical problems included thrombosis of the venous cannula (n=5), thrombus formation within the membrane oxygenator (n=2), membrane oxygenator plasma leakage (n=2), and membrane oxygenator contamination with Candida albicans. No bleeding complication was observed.

CONCLUSION

Pumpless extracorporeal lung assist is feasible and effective in a selected group of patients with acute respiratory distress syndrome but preserved hemodynamic function. By eliminating the pump and reducing the tubing length blood trauma can be minimized. Being very simple the system entails fewer risks of technical complications and also facilitates nursing care.

摘要

目的

长期体外肺辅助受严重机械性血液损伤限制,会导致出血和溶血。为减少体外肺辅助的缺点,已开发出一种新技术,体外循环的驱动力源自患者的动静脉压力梯度(无泵体外肺辅助)。本临床研究的目的是测试无泵体外肺辅助在急性呼吸窘迫综合征患者中的可行性和有效性。

方法

纳入20例(41±16岁)因各种原因导致急性呼吸窘迫综合征且呼吸治疗失败的患者。最低血流动力学要求包括心输出量(CO)>6升/分钟和平均动脉压(MAP)>70毫米汞柱。使用短路动静脉分流器建立无泵体外肺辅助,该分流器包括一个特别设计的低阻力膜式氧合器,置于患者双腿之间。

结果

纳入时所有患者的吸入氧分数(FiO₂)为1.0(动脉血氧分压[paO₂]45.9±7毫米汞柱,动脉血二氧化碳分压[paCO₂]58.9±17毫米汞柱)。无泵体外肺辅助24小时后,FiO₂降至0.8±0.1。氧合(paO₂84.1±21毫米汞柱,P<0.05)和二氧化碳清除(paCO₂32.7±5毫米汞柱,P<0.05)有显著改善。平均体外循环流量为2.6±0.6升/分钟,约占患者平均CO(10.8±2升/分钟)的25%。中位辅助时间为12±8(1 - 32)天。20例患者中有15例成功撤掉无泵体外肺辅助。20例患者中有5例在使用该系统期间死亡(4例败血症,1例心室颤动)。20例患者中有3例在成功撤机后的第8天、30天和50天分别死亡。20例患者中有12例康复出院(总生存率60%)。技术问题包括静脉插管血栓形成(n = 5)、膜式氧合器内血栓形成(n = 2)、膜式氧合器血浆渗漏(n = 2)以及膜式氧合器白色念珠菌污染。未观察到出血并发症。

结论

无泵体外肺辅助在选定的急性呼吸窘迫综合征但血流动力学功能良好的患者群体中是可行且有效的。通过去除泵并缩短管路长度,可将血液损伤降至最低。该系统非常简单,技术并发症风险较低,也便于护理。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验